Viewing Compound With Activities


Compound Report Overview

Compound Name: LANSOPRAZOLE
Compound Identifier: 700360
Mol Structure 2D: 700360
Molecular Weight: 369
Formula: C16 H14 F3 N3 O2 S
Development Status: US FDA Approved
SMILES: Cc1c(CS(=O)c2nc3ccccc3[nH]2)nccc1OCC(F)(F)F
Compound Literature
Compound Gene Type Activity Description View
LANSOPRAZOLE IC50 9.9 inhibits, enzyme activity, dog gastric mucosal microsomes View
LANSOPRAZOLE IC50 2.1 inhibits, activity/function of (H+ + K+)-ATPase, canine gastric microsomes, racemic lansoprazole View
LANSOPRAZOLE IC50 .082 inhibits, formation (acid, dibutyryl cAMP stimulated), isolated canine parietal cells, lansoprazole (-) View
LANSOPRAZOLE IC50 .059 inhibits, formation (acid, dibutyryl cAMP stimulated), isolated canine parietal cells, lansoprazole (+) View
LANSOPRAZOLE IC50 .007 inhibits, secretion (acid), rabbit isolated gastric glands View
LANSOPRAZOLE IC50 9.9 inhibits, enzyme activity, dog gastric mucosal microsomes View
LANSOPRAZOLE IC50 2.1 inhibits, activity/function of (H+ + K+)-ATPase, canine gastric microsomes, racemic lansoprazole View
LANSOPRAZOLE IC50 .082 inhibits, formation (acid, dibutyryl cAMP stimulated), isolated canine parietal cells, lansoprazole (-) View
LANSOPRAZOLE IC50 .059 inhibits, formation (acid, dibutyryl cAMP stimulated), isolated canine parietal cells, lansoprazole (+) View
LANSOPRAZOLE IC50 .007 inhibits, secretion (acid), rabbit isolated gastric glands View
LANSOPRAZOLE IC50 9.9 inhibits, enzyme activity, dog gastric mucosal microsomes View
LANSOPRAZOLE IC50 2.1 inhibits, activity/function of (H+ + K+)-ATPase, canine gastric microsomes, racemic lansoprazole View
LANSOPRAZOLE IC50 .082 inhibits, formation (acid, dibutyryl cAMP stimulated), isolated canine parietal cells, lansoprazole (-) View
LANSOPRAZOLE IC50 .059 inhibits, formation (acid, dibutyryl cAMP stimulated), isolated canine parietal cells, lansoprazole (+) View
LANSOPRAZOLE IC50 .007 inhibits, secretion (acid), rabbit isolated gastric glands View